Pfizer Inc..

ORGANIZATION

Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based

more

RELATED TO.

Viagra

DRUG

GALLERY.

$FILE- In this Thursday, July 12, 2012, file photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal. Pfizer Inc.\'s second-quarter net income jumped 25 percent as sharply lower costs for production, marketing and restructuring more than offset a plunge in revenue from cholesterol fighter Lipitor caused by generic competition. The Viagra maker said Tuesday, July 31, 2012, that net income was $3.25 billion, or 43 cents per share, up from $2.61 billion, or 33 cents per share, a year earlier.$

View full gallery

People walk past the Pfizer Inc. headquarters in New York, in this January 31, 2013 file photo. Pfizer Inc reported lower-than-expected quarterly earnings and revenue April 30, 2013, and the largest U.S. drugmaker trimmed its full-year profit outlook, sending shares down 5 percent in premarket trading.

This undated photo provided by pfizer shows Viagra pills. In a first for the drug industry, Pfizer Inc. told The Associated Press on May 6, 2013, that it will sell erectile dysfunction pill Viagra directly to patients on its website.

People walk past the Pfizer Inc. headquarters in New York, January 31, 2013. U.S. drugmaker Pfizer is expected to raise more than $2.2 billion through an initial public offering that will separate its animal health unit into a new company called Zoetis.

Principal scientists Charlie Holst, left, and Matt Drever pose for photographs at the Pfizer laboratory at the University of California at San Francisco (UCSF) Mission Bay campus in San Francisco, Tuesday, Dec. 18, 2012. Pfizer Inc., Astra Zeneca PLC and Eli Lilly and Co. are among the major international drug companies signing seven-figure, multi-year umbrella agreements with schools such as New York University, Harvard and the University of California-San Francisco. The deals cover a range of research projects and offer campus scientists access to once-proprietary experimental drug compounds owned by the corporate labs.

Pfizer Inc. CEO Ian Read arrives at the White House to attend a meeting of business leaders expected to meet with President Barack Obama and Vice President Biden at the White House in Washington, Wednesday, Nov. 28, 2012.

FILE- In this Thursday, July 12, 2012, file photo, Centrum multivitamins are shown on the packaging line at the Pfizer plant in Montreal. Pfizer Inc.'s second-quarter net income jumped 25 percent as sharply lower costs for production, marketing and restructuring more than offset a plunge in revenue from cholesterol fighter Lipitor caused by generic competition. The Viagra maker said Tuesday, July 31, 2012, that net income was $3.25 billion, or 43 cents per share, up from $2.61 billion, or 33 cents per share, a year earlier.

FIRSTPOST. ARTICLES View all